Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AFM283
AFM283
Affimed begins subject dosing in acute myeloid leukaemia therapy trial
Clinical Trials Arena
Thu, 03/30/23 - 10:12 am
Affimed
clinical trials
AFM283
AML